Nothing Special   »   [go: up one dir, main page]

BR9807271A - Tamoxifeno como terapia para reduzir diarréia induzida por cloridrato de irinotecano - Google Patents

Tamoxifeno como terapia para reduzir diarréia induzida por cloridrato de irinotecano

Info

Publication number
BR9807271A
BR9807271A BR9807271-4A BR9807271A BR9807271A BR 9807271 A BR9807271 A BR 9807271A BR 9807271 A BR9807271 A BR 9807271A BR 9807271 A BR9807271 A BR 9807271A
Authority
BR
Brazil
Prior art keywords
therapy
tamoxifen
irinotecan hydrochloride
induced diarrhea
reduce
Prior art date
Application number
BR9807271-4A
Other languages
English (en)
Inventor
Roger G Ulrich
Original Assignee
Pharmacia & Upjohn Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Spa filed Critical Pharmacia & Upjohn Spa
Publication of BR9807271A publication Critical patent/BR9807271A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"TAMOXIFENO COMO TERAPIA PARA REDUZIR DIARRéIA INDUZIDA POR CLORIDRATO DE IRINOTECANO". A presente invenção fornece um método para prevenir ou diminuir a diarréia associada à administração de irinotecano, compreendendo a administração de tamoxifeno pelos menos dois ciclos celulares antes da administração do irinotecano.
BR9807271-4A 1997-02-27 1998-02-24 Tamoxifeno como terapia para reduzir diarréia induzida por cloridrato de irinotecano BR9807271A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3918597P 1997-02-27 1997-02-27
PCT/US1998/002688 WO1998037892A1 (en) 1997-02-27 1998-02-24 Tamoxifen as a therapy to reduce irinotecan hydrochloride-induced diarrhea

Publications (1)

Publication Number Publication Date
BR9807271A true BR9807271A (pt) 2000-05-23

Family

ID=21904121

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9807271-4A BR9807271A (pt) 1997-02-27 1998-02-24 Tamoxifeno como terapia para reduzir diarréia induzida por cloridrato de irinotecano

Country Status (7)

Country Link
US (2) US5955466A (pt)
EP (1) EP1011675A1 (pt)
JP (1) JP2001513105A (pt)
AU (1) AU746875B2 (pt)
BR (1) BR9807271A (pt)
CA (1) CA2280855A1 (pt)
WO (1) WO1998037892A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6407117B1 (en) * 1998-06-18 2002-06-18 The George Washington University Method of administering camptothecin compounds for the treatment of cancer with reduced side effects
US6159935A (en) * 1999-11-29 2000-12-12 Pharmacia & Upjohn Co. Method for preventing diarrhea
DE60118547T2 (de) * 2000-05-15 2007-02-01 Celgene Corp. Pharmazeutische zusammensetzung zur behandlung von kolorektalem krebs welche thalidomid und irinotecan enthält
US20050032724A1 (en) * 2001-07-23 2005-02-10 Gunther Heinrich Methods for improved treatment of cancer with irinotecan based on mrp1
US20030092608A1 (en) * 2001-08-21 2003-05-15 Takayuki Kawaguchi Pharmaceutical composition for inhibiting the metastasis or preventing the recurrence of malignant tumor
WO2005105080A1 (en) * 2004-04-28 2005-11-10 Pfizer Products Inc. Combination therapy to treat diarrhea induced by cancer treatment

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE637389A (pt) * 1962-09-13
JPS6019790A (ja) * 1983-07-14 1985-01-31 Yakult Honsha Co Ltd 新規なカンプトテシン誘導体
US5786344A (en) * 1994-07-05 1998-07-28 Arch Development Corporation Camptothecin drug combinations and methods with reduced side effects

Also Published As

Publication number Publication date
US5955466A (en) 1999-09-21
WO1998037892A1 (en) 1998-09-03
AU6435298A (en) 1998-09-18
US6087377A (en) 2000-07-11
AU746875B2 (en) 2002-05-02
EP1011675A1 (en) 2000-06-28
CA2280855A1 (en) 1998-09-03
JP2001513105A (ja) 2001-08-28

Similar Documents

Publication Publication Date Title
BRPI0417820A (pt) heterociclos azabicìclicos como moduladores de receptor canabinóide
BRPI0417771A (pt) heterociclos azabicìclicos como moduladores de receptor canabinóides
BR0209129A (pt) Compostos, composições farmacêuticas, métodos para tratamento de dores, métodos para modulação de uma resposta farmacológica e usos de compostos
BR0014073A (pt) Pirazolopirimidinas como agentes terapêuticos
PT1039887E (pt) Metodos para o tratamento de neuro e nefro disturbios e de toxicidades terapeuticas usando compostos de aminotiol
BR0209658A (pt) Derivados de 4-amino-5-fenil-7-1ciclobutil-pirrolo [2,3-d] pirimidina
BR0209127A (pt) compostos, composições farmacêuticas, métodos para o tratamento de dores, métodos para a modulação de uma resposta farmacológica e usos de compostos
NO20042964L (no) Spiroazasykliske forbindelser som monoaminreseptormodulatorer
HN1999000124A (es) Derivados de pirazol substituido.
NO995349D0 (no) Multivalent vaksinasjonssammensetning med blandet baerer
BR0309855A (pt) Pirazolpiridinas substituìdas com carbamato
BRPI0411319A (pt) compostos terapeuticamente ativos e sua utilização
BR0008840A (pt) Derivados de camptotecina tendo atividade antitumoral
BR9911482A (pt) Composto, composição farmacêutica, uso do composto, e, processos para o tratamento ou profilaxia de doenças inflamatórias, e para a preparação de um composto
BR0307631A (pt) Piridinonas substituìdas como moduladores de p38 map-quinase
BRPI0411484A (pt) composto, formulação farmacêutica, métodos de tratamento ou prevenção de distúrbios de lipìdeo (dislipidemia), e de diabetes do tipo 2, uso de um composto, e, composição farmacêutica
BR0310099A (pt) método para tratar dislipidemia ou uma doença associada com a dislipidemia
BRPI0408990A (pt) derivados de pirimidin-4-ona e sua utilização como moduladores da p38-cinase
BRPI0418099A (pt) compostos, composição farmacêutica, e uso de um composto
BR0015992A (pt) Compostos, utilização dos mesmos, e, associações terapêuticas
BR0207487A (pt) Método de tratamento de tumores em mamìferos e uso de compostos de epotilona
AR008387A1 (es) Nuevas 5-fenoxialquil-tiazolidin-2,4-dionas, procedimientos para obtenerlas, nuevos compuestos intermedios de estos procedimientos ycomposiciones farmaceuticas que contienen las nuevas 5-fenoxialquil-tiazolidin- 2,4-dionas
BR0113590A (pt) 7-oxo-piridopirimidinas
BR0209128A (pt) Compostos, composições farmacêuticas, métodos para o tratamento de dores, métodos para a modulação de uma resposta farmacológica e usos de compostos
BR0208353A (pt) Compostos de diidropirimidina substituìdos com ciano e seu uso para tratar doenças

Legal Events

Date Code Title Description
B07A Technical examination (opinion): publication of technical examination (opinion) [chapter 7.1 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: ALTERADA DE INT.CL.8: A61K 31/138, A61P 1/12, A61K 31/47

Ipc: A61K 31/38, A61P 1/12, A61K 31/47

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PRESENTE PEDIDO DE PATENTE, DE ACORDO COM ART. 36 DA LPI (LEI 9279/96).